Money and Me: Less miles on these credit cards: smart credit card hacks
If you've been dismayed at the changes to your mile earn rates on your credit cards, we have you covered with credit card strategies to spend smarter. Hosted by Michelle Martin with guest Tim Phillips...
19 Kesä 202530min
Market View: Wilmar’s Woes, Nuclear Bets & Dollar Doubts
With U.S. markets closed for Juneteenth, Asia takes center stage. We break down the unfolding multi-trillion rupiah corruption probe rocking Wilmar International — a scandal dating back to Indonesia’s...
19 Kesä 202524min
Money and Me: Plan for Children's Uni and Boost your Retirement Funds?
How much does it really cost to send your child to uni - whether local or overseas? How will you fund this without compromising the build up of your retirement funds? Daniel Sim, Founder of Golden Goo...
18 Kesä 202527min
Market View: Bullish REITs, Wilmar Seizure Shock & Herbal Stock Surge
A herbal stock with zero revenue rockets 64,000%—what’s behind the madness? Michelle and Ryan unpack DBS’s latest bullish call on industrial REITs. Wilmar faces a billion-dollar graft probe in Indones...
18 Kesä 202523min
Money and Me: Global Bonds Break Out of the Mold
A rising tide of uncertainty is pushing investors out of the long end of the U.S. bond curve. Hosted by Michelle Martin, this episode explores what surging 30-year Treasury yields mean for your portfo...
17 Kesä 202514min
Market View: Oil Stocks Surge, WhatsApp Ads Arrive, IPOs Soar
Energy names rally, IPOs pop, and WhatsApp rewrites the rules. Hosted by Michelle Martin with Ryan Huang, this episode covers a spike in SGX-listed oil plays like Rex International and RH Petrogas. We...
17 Kesä 202517min
Money and Me: REITs Among Upcoming IPO's and what you need to know
Could 2025 be the year Singapore's REIT market regains its shine? With Centurion gearing up for a REIT IPO backed by worker and student housing, Keppel DC REIT reclaiming a spot on the STI, and Singap...
16 Kesä 202515min
Market View: Biotech Boom, REIT Buybacks, and the Stablecoin Shakeup
Chinese biotech stocks are breaking out—with deals involving Pfizer, Bristol-Myers Squibb, and BioNTech rewriting the playbook for global pharma partnerships. But will the rally last? Back in Singapor...
16 Kesä 202525min
